114 related articles for article (PubMed ID: 15680414)
1. Targeted lysis of HIV-infected cells by natural killer cells armed and triggered by a recombinant immunoglobulin fusion protein: implications for immunotherapy.
Gupta N; Arthos J; Khazanie P; Steenbeke TD; Censoplano NM; Chung EA; Cruz CC; Chaikin MA; Daucher M; Kottilil S; Mavilio D; Schuck P; Sun PD; Rabin RL; Radaev S; Van Ryk D; Cicala C; Fauci AS
Virology; 2005 Feb; 332(2):491-7. PubMed ID: 15680414
[TBL] [Abstract][Full Text] [Related]
2. GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody.
Tyler DS; Nastala CL; Stanley SD; Matthews TJ; Lyerly HK; Bolognesi DP; Weinhold KJ
J Immunol; 1989 Feb; 142(4):1177-82. PubMed ID: 2536767
[TBL] [Abstract][Full Text] [Related]
3. Chimeric zeta-receptors direct human natural killer (NK) effector function to permit killing of NK-resistant tumor cells and HIV-infected T lymphocytes.
Tran AC; Zhang D; Byrn R; Roberts MR
J Immunol; 1995 Jul; 155(2):1000-9. PubMed ID: 7608531
[TBL] [Abstract][Full Text] [Related]
4. Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS.
Iannello A; Debbeche O; Samarani S; Ahmad A
J Leukoc Biol; 2008 Jul; 84(1):1-26. PubMed ID: 18388298
[TBL] [Abstract][Full Text] [Related]
5. Concomitant killing in vitro of both gp120-coated CD4+ peripheral T lymphocytes and natural killer cells in the antibody-dependent cellular cytotoxicity (ADCC) system.
Jewett A; Cavalcanti M; Giorgi J; Bonavida B
J Immunol; 1997 Jun; 158(11):5492-500. PubMed ID: 9164972
[TBL] [Abstract][Full Text] [Related]
6. Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection.
Vieillard V; Costagliola D; Simon A; Debré P;
AIDS; 2006 Sep; 20(14):1795-804. PubMed ID: 16954720
[TBL] [Abstract][Full Text] [Related]
7. HIV inhibits early signal transduction events triggered by CD16 cross-linking on NK cells, which are important for antibody-dependent cellular cytotoxicity.
Lichtfuss GF; Meehan AC; Cheng WJ; Cameron PU; Lewin SR; Crowe SM; Jaworowski A
J Leukoc Biol; 2011 Jan; 89(1):149-58. PubMed ID: 20884651
[TBL] [Abstract][Full Text] [Related]
8. Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.
Terunuma H; Deng X; Dewan Z; Fujimoto S; Yamamoto N
Int Rev Immunol; 2008; 27(3):93-110. PubMed ID: 18437601
[TBL] [Abstract][Full Text] [Related]
9. A novel EGFP-CEM-NKr flow cytometric method for measuring antibody dependent cell mediated-cytotoxicity (ADCC) activity in HIV-1 infected individuals.
Kantakamalakul W; Pattanapanyasat K; Jongrakthaitae S; Assawadarachai V; Ampol S; Sutthent R
J Immunol Methods; 2006 Aug; 315(1-2):1-10. PubMed ID: 16884734
[TBL] [Abstract][Full Text] [Related]
10. Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination.
Iannello A; Debbeche O; Samarani S; Ahmad A
J Leukoc Biol; 2008 Jul; 84(1):27-49. PubMed ID: 18388299
[TBL] [Abstract][Full Text] [Related]
11. Mutual interference of HIV and natural killer cell-mediated immune response.
Jacobs R; Heiken H; Schmidt RE
Mol Immunol; 2005 Feb; 42(2):239-49. PubMed ID: 15488611
[TBL] [Abstract][Full Text] [Related]
12. Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density.
Niwa R; Sakurada M; Kobayashi Y; Uehara A; Matsushima K; Ueda R; Nakamura K; Shitara K
Clin Cancer Res; 2005 Mar; 11(6):2327-36. PubMed ID: 15788684
[TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent cell-mediated cytotoxicity can protect PBMC from infection by cell-associated HIV-1.
Hildreth JE; Hampton R; Halsey NA
Clin Immunol; 1999 Feb; 90(2):203-12. PubMed ID: 10080832
[TBL] [Abstract][Full Text] [Related]
14. Anti-HIV-1 ADCC: clinical and therapeutic implications.
Weinhold KJ
Biotechnol Ther; 1991; 2(1-2):147-57. PubMed ID: 1845118
[TBL] [Abstract][Full Text] [Related]
15. The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells.
Fischer L; Penack O; Gentilini C; Nogai A; Muessig A; Thiel E; Uharek L
Exp Hematol; 2006 Jun; 34(6):753-9. PubMed ID: 16728280
[TBL] [Abstract][Full Text] [Related]
16. Interaction of human immunoglobulin G with CD16 on natural killer cells: ligand clearance, FcgammaRIIIA turnover and effects of metalloproteinases on FcgammaRIIIA-mediated binding, signal transduction and killing.
Mota G; Moldovan I; Calugaru A; Hirt M; Kozma E; Galatiuc C; Brasoveanu L; Boltz-Nitulescu G
Scand J Immunol; 2004 Mar; 59(3):278-84. PubMed ID: 15030579
[TBL] [Abstract][Full Text] [Related]
17. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.
Fausther-Bovendo H; Sol-Foulon N; Candotti D; Agut H; Schwartz O; Debré P; Vieillard V
AIDS; 2009 Jun; 23(9):1077-87. PubMed ID: 19424050
[TBL] [Abstract][Full Text] [Related]
18. Specific targeting of CD33(+) leukemia cells by a natural killer cell line modified with a chimeric receptor.
Schirrmann T; Pecher G
Leuk Res; 2005 Mar; 29(3):301-6. PubMed ID: 15661266
[TBL] [Abstract][Full Text] [Related]
19. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC).
Moreno M; Mol BM; von Mensdorff-Pouilly S; Verheijen RH; von Blomberg BM; van den Eertwegh AJ; Scheper RJ; Bontkes HJ
Cancer Lett; 2008 Dec; 272(1):70-6. PubMed ID: 18684557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]